Therapeutics & Rare Diseases (00:57:23) Optimism
Only the concentration changes
(Some have theoretical worries that, for instance, BPC-157 might promote the growth of tumor cells.) On the other is an increasingly large and vocal cohort of experts and regular people who feel that the FDA, the pharmaceutical industry, and esteemed scientific institutions are gatekeeping potentially miraculous substances
The results are not directly comparable because the peptides are not equivalent products
Major trends: Rapid growth in CAR-T and gene-edited cell therapy approvals, Increasing demand for low-endotoxin, high-purity resins for viral vector capture, Adoption of automated, closed-system processing to reduce contamination risk, Development of specialized resin formulations for AAV and lentivirus purification, and Expansion of dedicated cell and gene therapy manufacturing facilities